El Segundo, California
United States
3
2025-06-26
2
2026-03-17
These are the the leading inventors for applications assigned to AlbuNext, LLC:
AlbuNext, LLC based in El Segundo, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Orally Available Albenatide
#2 | 2024-12-26 ✅ Patent 12,576,141 granted on 2026-03-17Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors
#3 | 2024-12-26 ✅ Patent 12,551,541 granted on 2026-02-17Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor
Also check out AlbuNext, LLC's (El Segundo, United States) applicant profile with 3 patent applications submitted.
632470 ⎘